Gliomas are aggressive brain tumors that are diagnosed in about 18,000 people each year in the USA. The prognosis is generally grim and the chances of survival very poor, as gliomas develop quickly and are beyond the reach of normal blood-borne treatments. A new drug that cuts off the blood supply to these tumors has been demonstrated to slow down their growth and offers the hope of a future combined therapy to treat them more efficiently.

Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.

Source: Science Daily